Renal Cell Carcinoma

RENAL CELL CARCINOMA ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials

A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
Closing the Gap Between Cancer Patients and Researchers: A Patient Advocate’s Perspective on GRASP

Patient advocate Marlena Murphy provides a patient’s perspective on GRASP.
The Past, Present, and Future of GRASP: Connecting Cancer Researchers, Clinicians, and Patient Advocates

GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
Underdosing in Patients With Cancer and Obesity: A Thing of the Past?

New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
Age and Race May Determine Whether Cancer Patients Access Their Electronic Health Records

Black cancer patients were 44% less likely than White patients to enroll in a portal that provides access to electronic health records.

RENAL CELL CARCINOMA NEWS

Study: Risk Score Should Guide Deferral of Cytoreductive Nephrectomy

July 18, 2021

Though uncommon, complete responses are seen among patients with metastatic disease, but CRs seem to

Demographic Factors Play Role in Non-Guideline-Based Treatment of Kidney Cancer

July 2, 2021

For the study, researchers conducted a literature review and network meta-analysis of phase 2/3 randomized controlled trials of approved first-line TKI therapies for mRCC.

Two-Drug Regimen Offers Better Health-Related Quality of Life in Advanced Renal Cell Carcinoma

June 8, 2021

In Patients With Renal Cell Carcinoma Receiving Everolimus, Acute Kidney Injury is Common

Telaglenastat Fails to Improve Outcomes in Previously Treated Metastatic RCC

June 7, 2021

There is great interest in evaluating the link between hypercalcemia and prognosis in ccRCC by researching the genes that influence calcium levels.

Combo Continues to Show Superior Efficacy vs Sunitinib in Advanced Clear Cell Renal Cell Carcinoma

June 7, 2021

Next post in Renal Cell Carcinoma

Though uncommon, complete responses are seen among patients with metastatic disease, but CRs seem to

Demographic Factors Play Role in Non-Guideline-Based Treatment of Kidney Cancer